Clinical trial
A Study of LXR015-1 in HIV-Infected Patients
NCT00002365 · LXR Biotechnology, Industry · Completed
Key facts
| NCT number | NCT00002365 |
|---|---|
| Title | A Study of LXR015-1 in HIV-Infected Patients |
| Official title | A Randomized, Parallel, Open-Label Phase I Study of LXR015-1 in HIV-Infected Patients |
| Lead sponsor | LXR Biotechnology, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | LXR015-1 |
| Enrollment | 30 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: